BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 30266249)

  • 1. Positive Surgical Margins Predict Progression-free Survival After Nephron-sparing Surgery for Renal Cell Carcinoma: Results From a Single Center Cohort of 459 Cases With a Minimum Follow-up of 5 Years.
    Tellini R; Antonelli A; Tardanico R; Fisogni S; Veccia A; Furlan MC; Carobbio F; Cozzoli A; Zanotelli T; Simeone C
    Clin Genitourin Cancer; 2019 Feb; 17(1):e26-e31. PubMed ID: 30266249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of surgical margin on cancer-specific survival in patients treated with nephron-sparing surgery.
    Kizilay F; Eskidemir U; Bahceci T; Simsir A; Ozdemir H; Sarsik B; Turna B
    Niger J Clin Pract; 2019 Oct; 22(10):1396-1402. PubMed ID: 31607729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncologic outcomes of patients with positive surgical margin after partial nephrectomy: a 25-year single institution experience.
    Petros FG; Metcalfe MJ; Yu KJ; Keskin SK; Fellman BM; Chang CM; Gu C; Tamboli P; Matin SF; Karam JA; Wood CG
    World J Urol; 2018 Jul; 36(7):1093-1101. PubMed ID: 29488096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive surgical margin following radical nephrectomy is an independent predictor of local recurrence and disease-specific survival.
    Abu-Ghanem Y; Ramon J; Berger R; Kaver I; Fridman E; Leibowitz-Amit R; Dotan ZA
    World J Surg Oncol; 2017 Nov; 15(1):193. PubMed ID: 29096642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, multicenter evaluation of predictive factors for positive surgical margins after nephron-sparing surgery for renal cell carcinoma: the RECORd1 Italian Project.
    Schiavina R; Serni S; Mari A; Antonelli A; Bertolo R; Bianchi G; Brunocilla E; Borghesi M; Carini M; Longo N; Martorana G; Mirone V; Morgia G; Porpiglia F; Rocco B; Rovereto B; Simeone C; Sodano M; Terrone C; Ficarra V; Minervini A
    Clin Genitourin Cancer; 2015 Apr; 13(2):165-70. PubMed ID: 25450033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive surgical margins after nephron-sparing surgery.
    Marszalek M; Carini M; Chlosta P; Jeschke K; Kirkali Z; Knüchel R; Madersbacher S; Patard JJ; Van Poppel H
    Eur Urol; 2012 Apr; 61(4):757-63. PubMed ID: 22136987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney autotransplantation after nephrectomy and work bench surgery as an ultimate approach to nephron-sparing surgery.
    Janssen MWW; Linxweiler J; Philipps I; Bütow Z; Siemer S; Stöckle M; Ohlmann CH
    World J Surg Oncol; 2018 Feb; 16(1):35. PubMed ID: 29463251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.
    Bensalah K; Pantuck AJ; Rioux-Leclercq N; Thuret R; Montorsi F; Karakiewicz PI; Mottet N; Zini L; Bertini R; Salomon L; Villers A; Soulie M; Bellec L; Rischmann P; De la Taille A; Avakian R; Crepel M; Ferriere JM; Bernhard JC; Dujardin T; Pouliot F; Rigaud J; Pfister C; Albouy B; Guy L; Joniau S; van Poppel H; Lebret T; Culty T; Saint F; Zisman A; Raz O; Lang H; Spie R; Wille A; Roigas J; Aguilera A; Rambeaud B; Martinez Piñeiro L; Nativ O; Farfara R; Richard F; Roupret M; Doehn C; Bastian PJ; Muller SC; Tostain J; Belldegrun AS; Patard JJ
    Eur Urol; 2010 Mar; 57(3):466-71. PubMed ID: 19359089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncologic outcomes of nephron-sparing surgery in patients with T1 multifocal renal cell carcinoma.
    Li G; Zhu D; Gao H; Chen H; Li Y; Niu Y
    Clin Transl Oncol; 2019 Jun; 21(6):760-765. PubMed ID: 30443869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncological outcomes and prognostic factors after nephron-sparing surgery in renal cell carcinoma.
    López-Costea MÁ; Bonet X; Pérez-Reggeti J; Etcheverry B; Vigués F
    Int Urol Nephrol; 2016 May; 48(5):681-6. PubMed ID: 26861062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Predictors of positive surgical margins after nephron-sparing surgery for renal cell carcinoma: retrospective analysis on 298 consecutive patients].
    Schiavina R; Borghesi M; Chessa F; Rizzi S; Martorana G
    Urologia; 2014; 81(1):40-5. PubMed ID: 24744214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive surgical margins with renal cell carcinoma have a limited influence on long-term oncological outcomes of nephron sparing surgery.
    Raz O; Mendlovic S; Shilo Y; Leibovici D; Sandbank J; Lindner A; Zisman A
    Urology; 2010 Feb; 75(2):277-80. PubMed ID: 19896179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of margin status on survival after radical nephrectomy for renal cell carcinoma.
    Morris LK; Altahan A; Gandhi J; Mays J; Giri U; Fleming M; Martin MG
    J Surg Oncol; 2021 Feb; 123(2):687-692. PubMed ID: 33333591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a role for partial nephrectomy in patients with metastatic renal cell carcinoma?
    Hellenthal NJ; Mansour AM; Hayn MH; Schwaab T
    Urol Oncol; 2013 Jan; 31(1):36-41. PubMed ID: 21396834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting positive surgical margins in partial nephrectomy: A prospective multicentre observational study (the RECORd 2 project).
    Schiavina R; Mari A; Bianchi L; Amparore D; Antonelli A; Artibani W; Brunocilla E; Capitanio U; Fiori C; Di Maida F; Gontero P; Larcher A; Li Marzi V; Longo N; Marra G; Montanari E; Porpiglia F; Roscigno M; Simeone C; Siracusano S; Tellini R; Terrone C; Villari D; Ficarra V; Carini M; Minervini A;
    Eur J Surg Oncol; 2020 Jul; 46(7):1353-1359. PubMed ID: 32007380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications.
    Haferkamp A; Kurosch M; Pritsch M; Hatiboglu G; Macher-Goeppinger S; Pfitzenmaier J; Pahernik S; Wagener N; Hohenfellner M
    Ann Surg Oncol; 2010 Feb; 17(2):544-51. PubMed ID: 19953334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-parenchyma interface and long-term oncologic outcomes after robotic tumor enucleation for sporadic renal cell carcinoma.
    Minervini A; Campi R; Di Maida F; Mari A; Montagnani I; Tellini R; Tuccio A; Siena G; Vittori G; Lapini A; Raspollini MR; Carini M
    Urol Oncol; 2018 Dec; 36(12):527.e1-527.e11. PubMed ID: 30268711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional and oncologic outcomes after nephron-sparing surgery in a solitary kidney: 10 years of experience.
    Costabel JI; Marchinena PG; Tirapegui F; Dantur A; Jurado A; Gueglio G
    Int Braz J Urol; 2016; 42(2):253-61. PubMed ID: 27256179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive surgical margins after nephron-sparing surgery for renal cell carcinoma: incidence, clinical impact, and management.
    Borghesi M; Brunocilla E; Schiavina R; Martorana G
    Clin Genitourin Cancer; 2013 Mar; 11(1):5-9. PubMed ID: 23083800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transperitoneal Robot-assisted Partial Nephrectomy with Minimum Follow-up of 5 Years: Oncological and Functional Outcomes from a Single Institution.
    Bertolo R; Garisto J; Dagenais J; Sagalovich D; Stein R; Fareed K; Gao T; Armanyous S; Fergany A; Lioudis M; Kaouk J
    Eur Urol Oncol; 2019 Mar; 2(2):207-213. PubMed ID: 31017098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.